GHRL and metabolic syndrome: The functional profiles of obestatin reported in the past studies would suggest a regulator of adipocyte metabolism by promoting adipogenesis in an autocrine/paracrine manner [2,3], which pointing to a putative role in the pathogenesis of metabolic syndrome.